| P50 | author | Lora Heisler | Q34004348 |
| P2093 | author name string | Alastair S Garfield | |
| P2860 | cites work | Increased anxiety of mice lacking the serotonin 1A receptor | Q24655613 |
| | Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens | Q24674037 |
| | Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats | Q24675513 |
| | Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors | Q28119146 |
| | Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine | Q28141684 |
| | Agonist diversity in 5-HT(2C) receptor-mediated weight control in rats | Q28235776 |
| | Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders | Q28260500 |
| | Serotonergic drugs : effects on appetite expression and use for the treatment of obesity | Q28282364 |
| | Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors | Q28284027 |
| | Serotonin 5-HT(2C) receptors regulate anxiety-like behavior | Q28298927 |
| | Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation | Q28307689 |
| | 5-HT1B receptors modulate components of satiety in the rat: behavioural and pharmacological analyses of the selective serotonin1B agonist CP-94,253 | Q28576396 |
| | WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity | Q28582332 |
| | Serotonin receptor 1A knockout: an animal model of anxiety-related disorder | Q28592514 |
| | Serotonin 2B receptor is required for heart development | Q28594131 |
| | Cycloalkyl[b][1,4]benzodiazepinoindoles are agonists at the human 5-HT2C receptor | Q33202316 |
| | Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group | Q34062887 |
| | Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors | Q34086043 |
| | Role of 5-hT2C receptors in the hypophagic effect of m-CPP, ORG 37684 and CP-94,253 in the rat. | Q34127528 |
| | Antiobesity effect of YM348, a novel 5-HT2C receptor agonist, in Zucker rats | Q34322399 |
| | No hypothermic response to serotonin in 5-HT7 receptor knockout mice | Q34331037 |
| | d-Fenfluramine- and d-norfenfluramine-induced hypophagia: differential mechanisms and involvement of postsynaptic 5-HT receptors. | Q34343637 |
| | 3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole | Q34349045 |
| | Involvement of 5-HT receptors in the regulation of food intake in Siberian hamsters. | Q34415764 |
| | Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task | Q34427413 |
| | CP-94, 253: a selective serotonin1B (5-HT1B) agonist that promotes satiety | Q34430733 |
| | Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503. | Q34487190 |
| | The potential use of selective 5-HT2C agonists in treating obesity | Q34497896 |
| | 5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents | Q34544813 |
| | Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization | Q34746665 |
| | 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential | Q34750267 |
| | Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine. | Q35026544 |
| | The role of the central melanocortin system in the regulation of food intake and energy homeostasis: lessons from mouse models | Q35140186 |
| | Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors | Q36509808 |
| | Sucrose intake and fasting glucose levels in 5-HT(1A) and 5-HT(1B) receptor mutant mice | Q36628828 |
| | Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes | Q36742750 |
| | Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice | Q36759748 |
| | The development of tolerance to drugs that suppress food intake | Q36976575 |
| | A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze. | Q38298172 |
| | Hyperphagia and Obesity Following Serotonin Depletion by Intraventricular p -Chlorophenylalanine | Q39764146 |
| | Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats. | Q41835936 |
| | Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor | Q42628634 |
| | Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors. | Q43729134 |
| | Male and female 5-HT1B receptor knockout mice have higher body weights than wildtypes | Q43854075 |
| | Intermittent, chronic fenfluramine administration to rats repeatedly suppresses food intake despite substantial brain serotonin reductions | Q43885953 |
| | Parabrachial infusion of D-fenfluramine reduces food intake. Blockade by the 5-HT(1B) antagonist SB-216641. | Q43913097 |
| | Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult | Q43937540 |
| | Activation of central melanocortin pathways by fenfluramine | Q44079737 |
| | 5-HT1B receptor knockout mice show a compensatory reduction in 5-HT2C receptor function. | Q44282784 |
| | Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT(2C) receptor mutant mice | Q44286362 |
| | Chronic paroxetine infusion influences macronutrient selection in male Sprague-Dawley rats | Q44384968 |
| | Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia. | Q44400212 |
| | Interaction between alpha-melanocyte-stimulating hormone and corticotropin-releasing hormone in the regulation of feeding and hypothalamo-pituitary-adrenal responses. | Q44566038 |
| | Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice. | Q44728718 |
| | Indoline derivatives as 5-HT(2C) receptor agonists. | Q44841742 |
| | Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice | Q44892908 |
| | Thermogenic effect of YM348, a novel 5-HT2C-receptor agonist, in rats | Q45162725 |
| | Pyrrolo(iso)quinoline derivatives as 5-HT(2C) receptor agonists | Q46780662 |
| | A null mutation of the serotonin 6 receptor alters acute responses to ethanol | Q46848285 |
| | d-fenfluramine in a rat model of dietary fat-induced obesity | Q46919401 |
| | Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine | Q47265863 |
| | Effect of chronic treatment with TFMPP, a 5-HT1 receptor agonist, on food intake, weight gain, plasma insulin and neuropeptide mRNA expression in obese Zucker rats | Q47395017 |
| | Sertraline, a serotonin-uptake inhibitor, reduces food intake and body weight in lean rats and genetically obese mice | Q47417622 |
| | Absence of Fenfluramine-Induced Anorexia and Reduced c-fos Induction in the Hypothalamus and Central Amygdaloid Complex of Serotonin 1B Receptor Knock-Out Mice | Q47892388 |
| | 5-HT(2C) receptor activation inhibits appetitive and consummatory components of feeding and increases brain c-fos immunoreactivity in mice. | Q48140056 |
| | Hyperphagia and Increased Growth in Rats After Intraventricular Injection of 5,7-Dihydroxytryptamine | Q48392267 |
| | Adrenergic innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A combined light and electron microscopic immunocytochemical study. | Q48406190 |
| | Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. | Q48437323 |
| | Effects of chronic fenfluramine administration on hypothalamic neuropeptide mRNA expression | Q48576769 |
| | Divergence of melanocortin pathways in the control of food intake and energy expenditure | Q48707234 |
| | Behavioral mechanisms for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting 5-HT agonists | Q48848141 |
| | Role of CRH in the effects of 5-HT-receptor agonists on food intake and metabolic rate | Q48874239 |
| | Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor | Q51090922 |
| | Sibutramine. A review of its contribution to the management of obesity | Q51565817 |
| | The 5-HT2 receptor agonist MK-212 reduces food intake and increases resting but prevents the behavioural satiety sequence | Q52868600 |
| | Locomotion is the major determinant of sibutramine-induced increase in energy expenditure | Q53598349 |
| | Serotonin Reciprocally Regulates Melanocortin Neurons to Modulate Food Intake | Q57912931 |
| | Reduction of Fat and Protein Intakes But Not Carbohydrate Intake Following Acute and Chronic Fluoxetine in Female Rats | Q57912933 |
| | Reduced satiating effect of d -fenfluramine in serotonin 5-HT 2C receptor mutant mice | Q60054745 |
| | 5-HT1B agonists induce anorexia at a postsynaptic site | Q60054778 |
| | Biochemical and behavioral studies of the 5-HT1B receptor agonist, CP-94,253 | Q61773287 |
| | The effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjects | Q69061405 |
| | Dissociation of the anorectic actions of 5-HTP and fenfluramine | Q70296148 |
| | Short-term effects of sibutramine (Reductil) on appetite and eating behaviour and the long-term therapeutic outcome | Q73588876 |
| | Fluoxetine Decreases Fat and Protein Intakes But Not Carbohydrate Intake in Male Rats | Q73784231 |
| | Effect of the antiobesity agent sibutramine in obese-diabetic ob/ob mice | Q77094351 |
| | Fluvoxamine, a selective serotonin reuptake inhibitor, and 5-HT2C receptor inactivation induce appetite-suppressing effects in mice via 5-HT1B receptors | Q80227491 |
| | A comparison of the effects of tryptamine and 5-hydroxytryptamine on feeding following injection into the paraventricular nucleus of the hypothalamus | Q93522813 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| | pharmacology | Q128406 |
| P304 | page(s) | 49-60 | |
| P577 | publication date | 2009-01-15 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Journal of Physiology | Q7743612 |
| P1476 | title | Pharmacological targeting of the serotonergic system for the treatment of obesity | |
| P478 | volume | 587 | |